These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 22348821)

  • 1. Cardiac phosphoproteome reveals cell signaling events involved in doxorubicin cardiotoxicity.
    Gratia S; Kay L; Michelland S; Sève M; Schlattner U; Tokarska-Schlattner M
    J Proteomics; 2012 Aug; 75(15):4705-16. PubMed ID: 22348821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rehabilitative exercise in a rat model of doxorubicin cardiotoxicity.
    Hydock DS; Lien CY; Jensen BT; Parry TL; Schneider CM; Hayward R
    Exp Biol Med (Maywood); 2012 Dec; 237(12):1483-92. PubMed ID: 23354407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of AMPK signalling by doxorubicin: at the crossroads of the cardiac responses to energetic, oxidative, and genotoxic stress.
    Gratia S; Kay L; Potenza L; Seffouh A; Novel-Chaté V; Schnebelen C; Sestili P; Schlattner U; Tokarska-Schlattner M
    Cardiovasc Res; 2012 Aug; 95(3):290-9. PubMed ID: 22461523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythropoietin modulates imbalance of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in doxorubicin-induced cardiotoxicity.
    Chen X; Guo Z; Wang P; Xu M
    Heart Lung Circ; 2014 Aug; 23(8):772-7. PubMed ID: 24685074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 6-gingerol ameliorated doxorubicin-induced cardiotoxicity: role of nuclear factor kappa B and protein glycation.
    El-Bakly WM; Louka ML; El-Halawany AM; Schaalan MF
    Cancer Chemother Pharmacol; 2012 Dec; 70(6):833-41. PubMed ID: 23014738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New signal transduction paradigms in anthracycline-induced cardiotoxicity.
    Ghigo A; Li M; Hirsch E
    Biochim Biophys Acta; 2016 Jul; 1863(7 Pt B):1916-25. PubMed ID: 26828775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights into doxorubicin-induced cardiotoxicity: the critical role of cellular energetics.
    Tokarska-Schlattner M; Zaugg M; Zuppinger C; Wallimann T; Schlattner U
    J Mol Cell Cardiol; 2006 Sep; 41(3):389-405. PubMed ID: 16879835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrocardiographic and biochemical evidence for the cardioprotective effect of vitamin E in doxorubicin-induced acute cardiotoxicity in rats.
    Puri A; Maulik SK; Ray R; Bhatnagar V
    Eur J Pediatr Surg; 2005 Dec; 15(6):387-91. PubMed ID: 16418954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amelioration of doxorubicin-induced cardiotoxicity by deferiprone in rats.
    Ammar el-SM; Said SA; Suddek GM; El-Damarawy SL
    Can J Physiol Pharmacol; 2011 Apr; 89(4):269-76. PubMed ID: 21526973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baicalein alleviates doxorubicin-induced cardiotoxicity via suppression of myocardial oxidative stress and apoptosis in mice.
    Sahu BD; Kumar JM; Kuncha M; Borkar RM; Srinivas R; Sistla R
    Life Sci; 2016 Jan; 144():8-18. PubMed ID: 26606860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview of cardiac pathology in relation to anthracycline cardiotoxicity.
    Ferrans VJ
    Cancer Treat Rep; 1978 Jun; 62(6):955-61. PubMed ID: 352510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carvedilol as a protector against the cardiotoxicity induced by anthracyclines (doxorubicin).
    Machado V; Cabral A; Monteiro P; Gonçalves L; Providência LA
    Rev Port Cardiol; 2008 Oct; 27(10):1277-96. PubMed ID: 19178029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of doxorubicin-induced acute cardiotoxicity by an experimental antioxidant compound.
    Deres P; Halmosi R; Toth A; Kovacs K; Palfi A; Habon T; Czopf L; Kalai T; Hideg K; Sumegi B; Toth K
    J Cardiovasc Pharmacol; 2005 Jan; 45(1):36-43. PubMed ID: 15613977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amelioration of doxorubicin-induced cardiac and renal toxicity by pirfenidone in rats.
    Giri SN; Al-Bayati MA; Du X; Schelegle E; Mohr FC; Margolin SB
    Cancer Chemother Pharmacol; 2004 Feb; 53(2):141-50. PubMed ID: 14564477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The modulatory effect of lithium on doxorubicin-induced cardiotoxicity in rat.
    Rahimi Balaei M; Momeny M; Babaeikelishomi R; Ejtemaei Mehr S; Tavangar SM; Dehpour AR
    Eur J Pharmacol; 2010 Sep; 641(2-3):193-8. PubMed ID: 20534381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardioprotective activity of standardized extract of Ficus racemosa stem bark against doxorubicin-induced toxicity.
    Ahmed F; Urooj A
    Pharm Biol; 2012 Apr; 50(4):468-73. PubMed ID: 22136326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic heart damage following doxorubicin treatment is alleviated by lovastatin.
    Henninger C; Huelsenbeck S; Wenzel P; Brand M; Huelsenbeck J; Schad A; Fritz G
    Pharmacol Res; 2015 Jan; 91():47-56. PubMed ID: 25462173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxorubicin-induced cardiac dysfunction is attenuated by ciclosporin treatment in mice through improvements in mitochondrial bioenergetics.
    Marechal X; Montaigne D; Marciniak C; Marchetti P; Hassoun SM; Beauvillain JC; Lancel S; Neviere R
    Clin Sci (Lond); 2011 Nov; 121(9):405-13. PubMed ID: 21605084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in myocardial energy metabolism induced by the anti-cancer drug doxorubicin.
    Tokarska-Schlattner M; Wallimann T; Schlattner U
    C R Biol; 2006 Sep; 329(9):657-68. PubMed ID: 16945832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Redox-proteomic analysis of doxorubicin-induced altered thiol activity in cardiomyocytes.
    Lin ST; Chou HC; Chen YW; Chan HL
    Mol Biosyst; 2013 Mar; 9(3):447-56. PubMed ID: 23340498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.